Tons of exciting new single-cell genomics tools have been showcased at #bioc2022 this week. Today @LambdaMoses presented SpatialFeatureExperiment, an S4 class extending SpatialExperiment, facilitating geospatial stats for spatial #scRNAseq using Voyager github.com/pachterlab/Voy… 1/
The design of SpatialFeatureExperiment and the plans for Voyager were formed from a careful study that @LambdaMoses conducted of the spatial transcriptomics field (published as the "Museum of Spatial Transcriptomics"): nature.com/articles/s4159… 2/
While there are several analysis tools for spatial transcriptomics data, and extensions of #scRNAseq platforms such as Seurat for spatial data, they have limitations in terms of the methods they implement from the field of geospatial statistics. 3/
Also there has also been a breakdown in #RStats when it comes to single-cell genomics, limiting the utility of SingleCellExperiment, and SpatialExperiment which extends it. 4/
By developing Voyager on SpatialFeatureExperiment, which extends SpatialExperiment, hopefully single-cell genomics in #Rstats can re-center itself on interoperable classes. Voyager is just being launched by @LambdaMoses, and will mature as spatial genomics technologies mature. 5/
The plan is not only to have a framework applicable to the many different assays that have been / are being developed, but also to incorporate the large body of work in geospatial statistics that has not been fully explored in the single-cell genomics community. 6/6
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The exciting reveal of Ultima Genomics last week was accompanied by the publication of four preprints. Intrigued by the potential of the technology, @sinabooeshaghi & I decided to take a look at the data. A 🧵 about our findings & a preprint we posted: biorxiv.org/content/10.110… 1/
Unfortunately, no data. No code. There is not even supplementary material, which the authors write "will be made available in the near future." 2/
Without data or code, obviously one cannot check the claims of the company. But in this case one cannot even understand the claims. E.g. the description for Fig. 2e in the Methods is useless without code to explain what was actually done to produce it. 3/
We weren't particularly interested in studying normalization, but faced a vexing problem related to normalizing feature barcodes. In scouring the literature for solutions to our problem, we became increasingly confused rather than enlightened about how to normalize our data. 2/
We started with the excellent recent review / expository article by @const_ae & @wolfgangkhuber that looks at strengths & weaknesses of many methods: biorxiv.org/content/10.110…. It became clear to us that a central question is how to normalize depth w/ gene count overdispersion. 3/
"..antibody-based and lipid-based methods are simple, straightforward and generally applicable to a wide range of single cell applications and platforms, while genetic cell labeling and chemical labeling with oligonucleotides can be more challenging." Huh? genomebiology.biomedcentral.com/articles/10.11…
Tagging with chemical oligos does not require design of antibodies to specific proteins. Hence it is essentially universal with respect to organism, which is why it can be used to multiplex, say, jellyfish. science.org/doi/10.1126/sc…
When I went on the job market for my first job after I had been a postdoc I applied to only 3 schools where I really wanted to go (why waste people's time?). I got only one job (@UCBerkeley). 1/
I obviously had no other offers, but someone else in my field (computational biology) who applied to a different department did. The chair of my department wrote to the dean and explained that it would be fair to start both of us at the same salary. 2/
The dean wrote back and declined, explaining that "while I agree with you that it would be the right thing to do, in the absence of an outside offer [for Lior] I cannot approve a salary beyond the minimum." I still have the letter. 3/